Trials / Unknown
UnknownNCT03218124
Optimal Remifentanil Concentration and Thyroidectomy
Optimal Effect Site Remifentanil Concentration for Smooth Extubation After Thyroid Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Cagliari · Academic / Other
- Sex
- All
- Age
- 18 Years – 67 Years
- Healthy volunteers
- Not accepted
Summary
The study is aimed at determining the remifentanil effect site concentration suppressing the cough at extubation after surgical thyroidectomy, performed under remifentanil/desflurane based general anesthesia, expressed as median and 95th percentile effective dose. Possible hemodynamic instability, respiratory depression or prolongation of awakening time are also sought.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Remifentanil Effect site concentration | After skin suture, a predetermined Effect site remifentanil concentration will be achieved. Starting from 1.5 ng/ml in the first patient and increased or decreased by 0.2 ng/ml intervals based on the previous patient response: up if cough present, down otherwise ("Dixon's up and down" method). |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2018-06-01
- Completion
- 2018-07-01
- First posted
- 2017-07-14
- Last updated
- 2017-07-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03218124. Inclusion in this directory is not an endorsement.